Standout Papers

Neoadjuvant Chemoimmunotherapy for NSCLC 2024 202669
  1. Neoadjuvant Chemoimmunotherapy for NSCLC (2024)
    Mark Sorin, Connor Prosty et al. JAMA Oncology

Immediate Impact

7 standout
Sub-graph 1 of 3

Citing Papers

The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation
2024 Standout
Non-small-cell lung cancer
2024 Standout
1 intermediate paper

Works of Connor Prosty being referenced

Neoadjuvant Chemoimmunotherapy for NSCLC
2024 Standout
Pneumocystis jirovecii pneumonia in people living with HIV: a review
2024

Author Peers

Author Last Decade Papers Cites
Connor Prosty 46 40 74 51 47 37 236
Gilles Safa 56 17 39 69 61 28 241
Taha Al‐Shaikhly 31 21 55 12 102 42 282
Engin Karakeçe 61 36 54 39 21 39 277
Elvira Mora 60 32 49 17 71 31 243
M Pulik 48 34 46 35 79 37 275
Εvgenia Papakonstantinou 74 70 81 26 20 31 287
Yoo Sang Baek 38 30 55 46 97 39 270
C. Belajouza 81 29 42 37 26 52 234
P. Berbis 48 38 34 27 63 32 260
Kim Kj 66 48 69 41 31 36 294

All Works

Loading papers...

Rankless by CCL
2026